The value of weekly high dose infusional 5-fluorouracil in the treatment of advanced colorectal cancer
Köhne, C.H.; Daniel, P.T.; Dörken, B.
Tumori 83(1 Suppl): S56-S60
1997
ISSN/ISBN: 0300-8916 PMID: 9154070 Document Number: 481594
Document emailed within 1 workday
Related Documents
Madajewicz, S.; Petrelli, N.; Rustum, Y.M.; Campbell, J.; Herrera, L.; Mittelman, A.; Perry, A.; Creaven, P.J. 1984: Phase I-Ii trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer Cancer Research 44(10): 4667-4669Martoni, A.; Cricca, A.; Guaraldi, M.; Covizzi, M.; Farris, A.; Pannuti, F. 1992: Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancer Anticancer Research 12(3): 607-612
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Colucci, G.; Maiello, E.; Leo, S.; Giuliani, F.; Pedicini, A.; Pezzella, G.; Valori, V.; Galetta, D.; Contillo, A.; Prete, F. 1994: Biochemical modulation of fluorouracil with high dose methotrexate or folinic acid in advanced colorectal cancer patients. Gruppo Oncologico dell' Italia Meridionale (GOIM) Anticancer Research 14(5b): 2157-2162
Van Cutsem, E.; Blijham, G.H. 1999: Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group Seminars in Oncology 26(1 Suppl. 5): 13-20
Klotz, H.P.; Weder, W.; Largiadèr, F. 1993: Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin Helvetica Chirurgica Acta 60(1-2): 283-286
Asano, M.; Mori, T.; Takahashi, K.; Yasuno, M. 1997: Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(1): 55-60
Konishi, K.; Yabushita, K.; Takada, O.; Kawamura, T.; Hasebe, K.; Tsugawa, K.; Maeda, K.; Kuroda, Y.; Tsuji, M.; Demachi, H. 1995: Biochemically modulated chemotherapy with high-dose L-leucovorin and 5-fluorouracil for multiple liver metastasis from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(7): 961-964
Kane, R.C.; Cashdollar, M.R.; Bernath, A.M. 1978: Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion Cancer Treatment Reports 62(10): 1521-1525
Zhang, H.-G.; Cai, R.-G.; Chen, S.-S.; Wu, F.; Chu, D.-T. 2007: 10-hydroxy-camptothecin plus fluorouracil/leucovorin for the treatment of patients with advanced colorectal cancer Zhonghua Yi Xue Za Zhi 87(21): 1462-1464
Grem, J.L.; Shoemaker, D.D.; Petrelli, N.J.; Douglass, H.O. 1987: Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma Cancer Treatment Reports 71(11): 1122
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Specenier, P.; Thomas, J. 1986: Weekly low-dose doxorubicin in advanced breast cancer Cancer Treatment Reports 70(6): 815
Fosså, S.D.; Kaalhus, O. 1985: Radiotherapy. Locally advanced colorectal cancer with and without 5-fluorouracil Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 105(6): 423-426
Jönsson, P.E.; Malmberg, M.; Ericsson, M.; Ryden, S. 1991: Weekly dose adriamycin as first line chemotherapy in advanced breast cancer Anticancer Research 11(2): 877-879
Li, J.-h.; Li, B.; Jiang, H.-r.; Zhong, M.-z. 2011: Weekly regimen of paclitaxel liposome combined with cisplatin and 5-fluorouracil continuous infusion in the treatment of advanced gastric carcinoma Zhonghua Zhong Liu Za Zhi 33(3): 229-231
Hsieh, C-Hsi.; Chen, Y-Jen.; Chang, K-Hwa.; Hsu, H-Hsien.; Liu, C-Kuo.; Hung, S-Kai.; Chen, H-Wen.; Lai, Y-Liang.; Hsu, T-Chi. 2006: Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer Anticancer Research 26(5b): 3709-3715
Zampino, M.G.; Lorizzo, K.; Rocca, A.; Locatelli, M.; Zorzino, L.; Manzoni, S.; Mazzetta, C.; Fazio, N.; Biffi, R.; De Braud, F. 2006: Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer Anticancer Research 26(3b): 2425-2428
Jin, M.L.; Yang, B.Q.; Zhang, W.; Ren, P. 1992: High dose mitomycin C for treatment of advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(8 Suppl): 1193-1196
Tchekmedyian, N.S.; Tait, N.; Abrams, J.; Aisner, J. 1988: High-dose megestrol acetate in the treatment of advanced breast cancer Seminars in Oncology 15(2 Suppl 1: 44-49